SWS Medical(SH:688410)2025-02-27 13:00Financial Performance - The company reported total operating revenue of RMB 56,727.54 million, a decrease of 17.80% compared to the previous year[3] - Net profit attributable to the parent company was RMB 7,406.25 million, down 61.92% year-on-year[3] - The basic earnings per share decreased by 61.84% to RMB 0.2310[3] - The net asset per share attributable to the parent company decreased by 32.78% to RMB 5.29[5] - The decline in profits was primarily due to the normalization of high-margin product sales following a policy-driven surge in the previous year[7] Assets and Capital - Total assets increased by 4.46% to RMB 202,211.12 million at the end of the reporting period[5] - The total share capital grew by 49.00% due to a stock dividend distribution of 0.49 shares per share[7] Market Position and Competitiveness - The market share of the company's blood dialysis machine equipment reached 15.97%, ranking first among domestic brands[6] - R&D investment significantly increased compared to the previous year, impacting net profit but strengthening long-term competitiveness[6] - The company is actively expanding its international market presence, with overseas revenue showing improvement[6]